Literature DB >> 21139810

Iron-binding proteins and C-reactive protein in Nipple Aspirate Fluids: role of Iron-driven inflammation in breast cancer microenvironment?

Ferdinando Mannello1, Gaetana A Tonti, Patrizia Simone, Daniela Ligi, Virginia Medda.   

Abstract

Breast cancer, a worldwide disease with increasing incidence, develops from ductal/lobular epithelium. Nipple aspirate fluid (NAF), secreted from the breast ducts and lobules, can be analyzed to assess metabolic activity in breast microenvironment. Premalignant and malignant cell alterations may produce biochemical signals that deliver inflammatory proteins to the site. C-reactive protein (CRP), acute-phase protein considered a prognostic marker of inflammation, is frequently over-expressed in invasive breast carcinomas. Starting from the evidence that soluble and cell-bound iron binding protein Ferritin (FTN) and Transferrin (TRF) are crucially involved in breast inflammation and cancer, the aim of the present study is to analyze in NAF (a ductal fluid mirroring the breast microenvironment noninvasively collected from healthy and proven breast cancer affected women, n=38), the concentrations of CRP, FTN and TRF through high sensitive immunoassays. We analysed also serum (n=35) and milk samples (n=20) from healthy subjects. The mean level of CRP in Cancer NAF was significantly higher than in NoCancer NAF (P < 0.0001), especially in postmenopausal patients. Moreover, in Cancer NAF we detected higher levels of TRF and FTN respect to NoCancer NAF (P<0.001). A highly significant positive correlation between FTN and CRP content (Y= 2322x + 6.196, r(2) = 0.651, P<0.0001) was found. These data may support the involvement of inflammation and deregulation of iron homeostasis in breast cancer etio-pathogenesis. The significant accumulation of CRP in NAF in conjunction to the disruption of iron homeostasis may help to identify women at higher breast cancer risk.

Entities:  

Keywords:  Breast cancer; ferritin; inflammation; iron; nipple aspirate fluid; transferrin

Year:  2010        PMID: 21139810      PMCID: PMC2981430     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  53 in total

1.  C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

Authors:  Claire Siemes; Loes E Visser; Jan-Willem W Coebergh; Ted A W Splinter; Jacqueline C M Witteman; André G Uitterlinden; Albert Hofman; Huibert A P Pols; Bruno H Ch Stricker
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

Review 2.  Critical steps in breast carcinogenesis.

Authors:  J Russo; G Calaf; N Sohi; Q Tahin; P L Zhang; M E Alvarado; S Estrada; I H Russo
Journal:  Ann N Y Acad Sci       Date:  1993-11-30       Impact factor: 5.691

Review 3.  [Inflammatory markers, especially the mechanism of increased CRP].

Authors:  T Kawai
Journal:  Rinsho Byori       Date:  2000-08

Review 4.  Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.

Authors:  S Eva Singletary; James L Connolly
Journal:  CA Cancer J Clin       Date:  2006 Jan-Feb       Impact factor: 508.702

Review 5.  Inflammation and cancer: breast cancer as a prototype.

Authors:  Alberto Mantovani; Federica Marchesi; Chiara Porta; Antonio Sica; Paola Allavena
Journal:  Breast       Date:  2007-08-30       Impact factor: 4.380

6.  Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

Authors:  Kristine H Allin; Stig E Bojesen; Børge G Nordestgaard
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

7.  Concentration of aluminium in breast cyst fluids collected from women affected by gross cystic breast disease.

Authors:  Ferdinando Mannello; Gaetana A Tonti; Philippa D Darbre
Journal:  J Appl Toxicol       Date:  2009-01       Impact factor: 3.446

8.  C-reactive protein and risk of breast cancer.

Authors:  Shumin M Zhang; Jennifer Lin; Nancy R Cook; I-Min Lee; JoAnn E Manson; Julie E Buring; Paul M Ridker
Journal:  J Natl Cancer Inst       Date:  2007-06-06       Impact factor: 13.506

9.  Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease.

Authors:  Wenyi Qin; Weizhu Zhu; Colette Wagner-Mann; Edward R Sauter
Journal:  Ann Surg Oncol       Date:  2003-10       Impact factor: 5.344

Review 10.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

View more
  3 in total

1.  Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.

Authors:  Ali Shidfar; Tolulope Fatokun; David Ivancic; Robert T Chatterton; Seema A Khan; Jun Wang
Journal:  Horm Cancer       Date:  2016-04-19       Impact factor: 3.869

2.  NUDT21 Suppresses Breast Cancer Tumorigenesis Through Regulating CPSF6 Expression.

Authors:  Bi-Jun Wang; Da-Chao Liu; Qian-Ying Guo; Xiao-Wen Han; Xiao-Min Bi; Hao Wang; Zheng-Sheng Wu; Wen-Yong Wu
Journal:  Cancer Manag Res       Date:  2020-05-01       Impact factor: 3.989

Review 3.  Nipple Aspirate Fluid at a Glance.

Authors:  Susana I S Patuleia; Karijn P M Suijkerbuijk; Elsken van der Wall; Paul J van Diest; Cathy B Moelans
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.